Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital

Document Type : Abstracts

Abstract

According to many studies, mesenchymal stem cell (MSC) therapy derived from adipose tissue is one of the best therapeutic approaches for the treatment of type 1 diabetes. Indeed, MSCs have several characteristics: ease of harvesting and isolation, abundance, their potential to differentiate into multiple lineages, secretion of various cytokines and growth factors, as well as their immunomodulatory effects. 
Egyptian Society of Diabetes and Lipidology Journal
Volume 3, Issue 2
October 2023

Files

Share

How to cite

Statistics